Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
5.89
-0.16 (-2.64%)
At close: Feb 20, 2026, 4:00 PM EST
6.48
+0.59 (10.02%)
After-hours: Feb 20, 2026, 7:44 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $61.36 million as of February 20, 2026. Its market cap has increased by 292.92% in one year.
Market Cap
61.36M
Enterprise Value
59.82M
1-Year Change
292.92%
Ranking
Category
Stock Price
$5.89
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $61.36M, a decrease of -4.54%. That is a compound annual growth rate of -1.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 61.36M | 109.25% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 65.73M |
| Q32 Bio | 65.52M |
| Coeptis Therapeutics Holdings | 65.26M |
| Instil Bio | 62.12M |
| Alterity Therapeutics | 61.52M |
| MindWalk Holdings | 61.17M |
| InflaRx | 60.61M |
| Grace Therapeutics | 60.04M |